Fractional exhaled NO (FeNO) is universally considered an indirect marker of eosinophilic airways inflammation, playing an important role in the physiopathology of childhood asthma. Advances in technology and standardization have allowed a wider use of FeNO in clinical practice in children from the age of four years. FeNO measurements add a new dimension to the traditional clinical tools (symptoms scores, lung function tests) in the assessment of asthma. To date a number of studies have suggested a possible use of FeNO in early identification of exacerbation risk and in inhaled corticosteroids titration. The aim of this paper is to address practical issues of interest to paediatric clinicians who are attempting to use FeNO measurements as an adjunctive tool in the diagnosis and management of childhood airway diseases.
|Autori:||Piacentini GL; Cattazzo E; Tezza G; Peroni DG.|
|Titolo:||Exhaled nitric oxide in pediatrics: what is new for practice purposes and clinical research in children?|
|Anno del prodotto:||2012|
|Digital Object Identifier (DOI):||10.1088/1752-7155/6/2/027103|
|Appare nelle tipologie:||1.1 Articolo in rivista|